EMID: Intra-ductal Confocal Endomicroscopy for Characterization of Pancreas and Bile Duct Tumor

Sponsor
Institut Paoli-Calmettes (Other)
Overall Status
Completed
CT.gov ID
NCT00930410
Collaborator
(none)
50
2
1
44
25
0.6

Study Details

Study Description

Brief Summary

The endomicroscopy is an adaptation of traditional optical microscopy in the digestive endoscopy. Furthermore, with the integration of a miniaturized laser confocal microscope to a videoendoscope, it's possible to study the digestive mucous by "optical biopsy". This monocentric, non randomized and prospective study uses the Intra-ductal confocal endomicroscopy for the characterization of pancreas and bile duct tumor.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Endoscopic Retrograde Cholangio-Pancreatography (ERCP)
N/A

Detailed Description

Primary objective:

Obtain a tissular characterization of a biliary or pancreatic stenosis with a confocal microscope which is in direct contact of the stenosis during the Endoscopic Retrograde Cholangio-Pancreatography (ERCP).

Secondary objectives:
  • Compare the result of this "optical biopsy" to a conventional biopsy.

  • Tolerance

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Intra-ductal Confocal Endomicroscopy for Characterization of Pancreas and Bile Duct Tumor
Study Start Date :
Sep 1, 2008
Actual Primary Completion Date :
May 1, 2012
Actual Study Completion Date :
May 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: endomicroscopy

Utilisation of an intra-ductal confocal endomicroscopy during the endoscopic Retrograde Cholangio-Pancreatography

Procedure: Endoscopic Retrograde Cholangio-Pancreatography (ERCP)
Utilisation of the Intra-ductal confocal endomicroscopy to obtain any exploitable image for the anatomopathology.

Outcome Measures

Primary Outcome Measures

  1. The principal outcome is the percentage of successful in vivo examination according to the localisation of the stenosis. A successful examination is defined by the obtention of exploitable image for the anatomopathology. [2 days]

Secondary Outcome Measures

  1. Study of the concordance between optical and histological biopsy [2 days]

  2. Frequency and grade of adverse effects induced by the confocal endomicroscopy [2 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients aged from 18 to older

  • Patient with an inflammatory or tumoral stenosis of bile duct or a solid or cystic tumor in the pancreas with a dilatation of the principal pancreatic canal.

  • Signed consent

Non inclusion Criteria:
  • Patient who have no indication for an ERCP

  • Allergy to fluorescein

  • Allergic rhinitis, asthma, eczema

  • Pregnancy, breast feeding

  • Patients with dialysis

  • Patient with severe heart failure

  • Patient with cirrhosis

  • Hemostasis failure which can induce difficulties or contraindication for the biopsy during the conventional endoscopy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Institut PAOLI-CALMETTES Marseille France
2 Centre Hospitalier Princesse Grasse Monaco Monaco

Sponsors and Collaborators

  • Institut Paoli-Calmettes

Investigators

  • Principal Investigator: Marc GIOVANNINI, MD, Institut Paoli-Calmettes

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Institut Paoli-Calmettes
ClinicalTrials.gov Identifier:
NCT00930410
Other Study ID Numbers:
  • EMID/IPC 2008-001
First Posted:
Jun 30, 2009
Last Update Posted:
Mar 20, 2013
Last Verified:
Mar 1, 2013

Study Results

No Results Posted as of Mar 20, 2013